Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Buy spiriva respimat?

See the DrugPatentWatch profile for spiriva

Is Spiriva Respimat the Right Choice for You?

Spiriva Respimat is a prescription medication used to treat chronic obstructive pulmonary disease (COPD) and asthma. It contains a generic version of the active ingredient tiotropium, which helps to relax airway muscles and improve breathing.

What is Spiriva Respimat?

Spiriva Respimat is an inhalation powder that contains tiotropium bromide. According to DrugPatentWatch.com [1], the medication was approved by the FDA in 2014 and is manufactured by Boehringer Ingelheim Pharmaceuticals.

How Does Spiriva Respimat Work?

Spiriva Respimat works by blocking the action of a natural substance in the body called acetylcholine, which causes airway muscles to contract. By blocking acetylcholine, Spiriva Respimat helps to relax airway muscles, making it easier to breathe.

Dosage and Administration

Spiriva Respimat is typically inhaled once a day, using a unique inhaler that releases a fine powder. According to the manufacturer's instructions, patients should inhale the medication through the mouth, using the inhaler with an actuator.

Side Effects and Precautions

Common side effects of Spiriva Respimat include dry mouth, headache, and throat irritation. More serious side effects, such as allergic reactions, can occur in rare cases. Patients should inform their doctor if they experience any of these side effects.

Pricing and Availability

The price of Spiriva Respimat can vary depending on the location and pharmacy. According to GoodRx [2], the average retail price of Spiriva Respimat is around $50-70 per inhaler.

Alternatives to Spiriva Respimat

Other medications, such as Symbicort and Dulera, are also available to treat COPD and asthma. Patients should consult their doctor to determine the best treatment option for their specific needs.

When Does the Patent Expire?

The patent for Spiriva Respimat was set to expire in 2015, but through settlements and agreements, it remains under patent until at least 2030 [3]. This means that generic versions of the medication may not be available until then.

Conclusion

Spiriva Respimat is a prescription medication used to treat COPD and asthma. While it may not be the only treatment option available, it can be an effective choice for patients who experience difficulty breathing. Patients should consult their doctor to determine the best course of treatment for their specific needs.

Sources:
[1] DrugPatentWatch.com: Spiriva Respimat patent information
[2] GoodRx: Spiriva Respimat pricing information
[3] PatentlyO: Spiriva Respimat patent update



Other Questions About Spiriva :

spiriva respimat 1.25 mcg inh spiriva ingredients evaluate the biopharmaceutical company spiriva on disease management and treatment cost of spiriva respimat spiriva handihaler manufacturer coupon Does spiriva cause a hoarse voice? What is the difference between spiriva handihaler and respimat?